EW logo

Edwards Lifesciences (EW) Current Assets

Annual Current Assets

N/A

December 1, 2024


Summary


Performance

EW Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherEWbalance sheetmetrics:

Quarterly Current Assets

N/A

December 1, 2024


Summary


Performance

EW Quarterly Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherEWbalance sheetmetrics:

Current Assets Formula

Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets

EW Current Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--
3 y3 years--
5 y5 years--

EW Current Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall time

Edwards Lifesciences Current Assets History

DateAnnualQuarterly
Sep 2024
-
$6.73 B(+49.0%)
Jun 2024
-
$4.52 B(+8.3%)
Mar 2024
-
$4.17 B(+3.3%)
Dec 2023
$5.33 B(+2.5%)
$4.04 B(-0.8%)
Sep 2023
-
$4.07 B(+11.5%)
Jun 2023
-
$3.65 B(+12.0%)
Mar 2023
-
$3.26 B(+5.2%)
Dec 2022
$5.20 B(-2.4%)
$3.10 B(-11.9%)
Sep 2022
-
$3.51 B(+7.7%)
Jun 2022
-
$3.26 B(+0.7%)
Mar 2022
-
$3.24 B(+1.9%)
Dec 2021
$5.32 B(+28.4%)
$3.18 B(-9.5%)
Sep 2021
-
$3.52 B(+5.8%)
Jun 2021
-
$3.32 B(+8.3%)
Mar 2021
-
$3.07 B(-0.7%)
Dec 2020
$4.15 B(+18.3%)
$3.09 B(+3.7%)
Sep 2020
-
$2.98 B(+10.8%)
Jun 2020
-
$2.69 B(+7.3%)
Mar 2020
-
$2.51 B(-16.0%)
Dec 2019
$3.50 B(+15.4%)
$2.98 B(+8.9%)
Sep 2019
-
$2.74 B(+16.4%)
Jun 2019
-
$2.35 B(-0.6%)
Mar 2019
-
$2.37 B(+3.6%)
Dec 2018
$3.04 B(-2.6%)
$2.29 B(-21.5%)
Sep 2018
-
$2.91 B(+8.0%)
Jun 2018
-
$2.70 B(-0.8%)
Mar 2018
-
$2.72 B(+6.6%)
Dec 2017
$3.12 B(+37.3%)
$2.55 B(-0.7%)
Sep 2017
-
$2.57 B(+12.4%)
Jun 2017
-
$2.28 B(+13.1%)
Mar 2017
-
$2.02 B(-9.9%)
Dec 2016
$2.27 B(+13.0%)
$2.24 B(+3.2%)
Sep 2016
-
$2.17 B(+9.4%)
Jun 2016
-
$1.99 B(+9.1%)
Mar 2016
-
$1.82 B(-11.2%)
Dec 2015
$2.01 B(+55.5%)
$2.05 B(-4.5%)
Sep 2015
-
$2.15 B(-6.6%)
Jun 2015
-
$2.30 B(+1.9%)
Mar 2015
-
$2.25 B(+1.1%)
Dec 2014
$1.29 B(+31.3%)
$2.23 B(-3.4%)
Sep 2014
-
$2.31 B(+1.4%)
Jun 2014
-
$2.28 B(+42.1%)
Mar 2014
-
$1.60 B(-7.1%)
Dec 2013
$984.10 M(+5.9%)
$1.73 B(+9.9%)
Sep 2013
-
$1.57 B(+12.9%)
Jun 2013
-
$1.39 B(+2.2%)
Mar 2013
-
$1.36 B(+5.3%)
Dec 2012
$929.60 M
$1.29 B(-6.9%)
Sep 2012
-
$1.39 B(+8.5%)
Jun 2012
-
$1.28 B(+7.6%)
DateAnnualQuarterly
Mar 2012
-
$1.19 B(+1.7%)
Dec 2011
$812.00 M(+10.5%)
$1.17 B(-1.1%)
Sep 2011
-
$1.18 B(-2.9%)
Jun 2011
-
$1.22 B(+5.8%)
Mar 2011
-
$1.15 B(+11.4%)
Dec 2010
$734.60 M(+1.1%)
$1.03 B(+4.1%)
Sep 2010
-
$992.40 M(+8.0%)
Jun 2010
-
$918.90 M(+5.3%)
Mar 2010
-
$872.70 M(-1.9%)
Dec 2009
$726.30 M(+2.5%)
$889.20 M(+1.4%)
Sep 2009
-
$877.20 M(+17.7%)
Jun 2009
-
$745.60 M(+14.9%)
Mar 2009
-
$649.00 M(-6.2%)
Dec 2008
$708.30 M(-7.2%)
$691.90 M(+2.3%)
Sep 2008
-
$676.30 M(+6.5%)
Jun 2008
-
$635.10 M(+7.4%)
Mar 2008
-
$591.60 M(+1.7%)
Dec 2007
$763.40 M(+6.7%)
$581.70 M(+3.0%)
Sep 2007
-
$564.80 M(+4.4%)
Jun 2007
-
$541.20 M(-0.2%)
Mar 2007
-
$542.10 M(+2.0%)
Dec 2006
$715.20 M(+0.0%)
$531.60 M(+1.3%)
Sep 2006
-
$524.90 M(-3.2%)
Jun 2006
-
$542.30 M(+3.1%)
Mar 2006
-
$526.00 M(+2.3%)
Dec 2005
$714.90 M(-4.1%)
$514.20 M(+19.5%)
Sep 2005
-
$430.40 M(-1.5%)
Jun 2005
-
$437.10 M(+9.1%)
Mar 2005
-
$400.60 M(+9.0%)
Dec 2004
$745.20 M(+0.5%)
$367.50 M(+12.7%)
Sep 2004
-
$326.20 M(-2.1%)
Jun 2004
-
$333.30 M(+2.0%)
Mar 2004
-
$326.70 M(-9.3%)
Dec 2003
$741.20 M(+8.3%)
$360.20 M(-2.2%)
Sep 2003
-
$368.30 M(-5.1%)
Jun 2003
-
$388.20 M(+10.6%)
Mar 2003
-
$351.10 M(+9.7%)
Dec 2002
$684.20 M(-1.0%)
$320.20 M(+7.7%)
Sep 2002
-
$297.30 M(-4.6%)
Jun 2002
-
$311.70 M(+8.6%)
Mar 2002
-
$287.00 M(-1.7%)
Dec 2001
$690.90 M(-14.3%)
$292.00 M(+6.2%)
Sep 2001
-
$274.90 M(-13.1%)
Jun 2001
-
$316.20 M(+3.2%)
Mar 2001
-
$306.40 M(+1.8%)
Dec 2000
$806.00 M(-25.4%)
$301.00 M(+8.6%)
Sep 2000
-
$277.20 M(-6.0%)
Jun 2000
-
$295.00 M(-7.2%)
Mar 2000
-
$318.00 M
Dec 1999
$1.08 B
-

FAQ

  • What is the all time high annual current assets for Edwards Lifesciences?
  • What is the all time high quarterly current assets for Edwards Lifesciences?

What is the all time high annual current assets for Edwards Lifesciences?

Edwards Lifesciences all-time high annual total current assets is $4.04 B

What is the all time high quarterly current assets for Edwards Lifesciences?

Edwards Lifesciences all-time high quarterly total current assets is $6.73 B